DFX Intelligence
Family office profile
A••••• A•••• A•
The office, people and counterparty names on this page are hidden. Create a free account to reveal 5 records a month, or get Family Office Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Freiburg im Breisgau, Germany (Habsburgerstr. 91)Single family office (confirmed)identity confidence 75%Top 500 by research priority
Why this class: M••••• F•••'s own biography (s•••••••.de, independent of our GlobeNewswire source) names him managing director of 'the single-family office A••••• Holding GmbH' and separately confirms he is a shareholder of Dr. F••• Pharma 'from the F••• family' (per a related search summary on his H••• and F••• Pharma background); A••••• Holding GmbH is the parent entity of A••••• Asset GmbH per German commercial-register data (Northdata)..
Verified Sep 21, 2026 (yesterday)
Last observed Sep 21, 2026 · 13 observations · 2 sources
2 people · 1 investments · 0 public positions · 5 events
Direct investing
15
moderate
Co-investment
80
high
Each reading is 0 to 100 from the listed components in the evidence section; hover a tile for what it measures. No evidence yet of: external managers, private markets, sponsor-friendly, real estate.
Overviewshow
Profile completeness 47% (high value, high value shallow; the most valuable missing fact is contacts)
identityclassificationwealth origincapital-scale evidencepeoplecontactsmandatedirect investmentsfund relationshipsco-investorssponsor relationshipsreal estatepublic holdingsrecent eventsprovenancefreshness
- Classification
- Single family office (confirmed)
- Description
- unknown
- Headquarters
- Freiburg im Breisgau, Germany (Habsburgerstr. 91)
- Office address
- unknown
- Business phone
- unknown
- Website
- unknown
- Year established
- unknown
- Assets under management
- unknown
- Capital scale
- Reported office AUM: unknown. No public number of any kind.
Classification history
- Sep 15, 2026Single family office (confirmed) 75%M••••• F•••'s own biography (s•••••••.de, independent of our GlobeNewswire source) names him managing director of 'the single-family office A••••• Holding GmbH' and separately confirms he is a shareholder of Dr. F••• Pharma 'from the F••• family' (per a related search summary on his H••• and F••• Pharma background); A••••• Holding GmbH is the parent entity of A••••• Asset GmbH per German commercial-register data (Northdata).Factverifiedsmartbax.de“••• Locked”
- Sep 14, 2026Single family office (probable) 70%a press release by s••••••• GmbH describes it as a single family office (cited)Fact
Family and wealth originshow
- Family served
- F••• family
- Source of wealth
- ••• Locked
- Operating company origin
- unknown
Team2 peopleshow
| Person | Title | Responsibility | Business contact | Source |
|---|---|---|---|---|
| D•• M••••• F••• family | Managing Director, A••••• Asset / A••••• Holding GmbH | Leadership · investment decisions | none on record | smartbax.de Fact |
| D•• M••••• F••• | Managing Director | Leadership | none on record | smartbax.de Fact |
Investment mandateshow
••• Locked
Stated (their words, cited)
- Sectors
- ••• Locked Fact smartbax.de“••• Locked”
- Invests directly
- ••• Locked Fact biospace.com“••• Locked”
Observed (from the investment record)
- States
- none Fact
- Control
- minority (1) Fact
- Sectors
- biotech (antimicrobial resistance / antibiotics) (1) Fact
- Subsectors
- none Fact
- Co investors
- B••••• K•••••• (1), U••••••••• F•••••• f•• I••••••••• (1), H••• • H•••••••• G••••••••• (1), B••••••••• I•••••••• V•••••• F••• ••••• (1) Fact
- Asset classes
- venture capital / life sciences (1) Fact
- Direct vs fund
- Fund: 0 · Direct: 1 · Real estate: 0 Fact
- Sponsors backed
- none Fact
- Investment count
- 1 Fact
- Investment kinds
- venture financing, lead investor (1) Fact
- First and last deal
- Last: 2025-10-22 · First: 2025-10-22 Fact
- Lead vs participant
- lead (1) Fact
- Disclosed check sizes
- Max: unknown · Min: unknown · Count: 0 Fact••• Locked
Inferred (regulatory shape and team)
Nothing to infer from.
- Invests directly
- A••••• Asset led a €4.7M Pre-Series A venture round in biotech company s••••••• alongside B••••• K••••••
- Allocates to managers
- unknown
- Asset classes
- unknown
- Sectors
- The office's direct investing centers on venture capital, with a background and focus in healthcare/pharma
- Geography
- unknown
- Check size
- unknown
Direct investments1 dealsshow
| Date | Company | Kind | Sector | Role | Amount | With | Source |
|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | s••••••• | Venture financing, lead investor | biotech (antimicrobial resistance / antibiotics) | lead · minority | unknown | B••••• K•••••• (co investor), U••••••••• F•••••• f•• I••••••••• (co investor), H••• • H•••••••• G••••••••• (co investor), B••••••••• I•••••••• V•••••• F••• ••••• (co investor) | biospace.com Fact “••• Locked” |
Fund and manager relationshipsshow
No fund commitment or manager relationship on the record. Commitment amounts are shown only when public.
Public stakes and holdingsshow
Form 13F holdings
No 13F filing on the record for this office.
Real estateshow
No documented real estate ownership link. A property is attributed to an office only through a documented control relationship, never from a surname.
Co-investors4show
| Counterparty | Kind | Shared deals | First, last | Examples | Source |
|---|---|---|---|---|---|
| U••••••••• F•••••• f•• I••••••••• | organisation | 1 | Oct 22, 2025 | s••••••• | biospace.com |
| B••••• K•••••• | organisation | 1 | Oct 22, 2025 | s••••••• | biospace.com |
| B••••••••• I•••••••• V•••••• F••• ••••• | organisation | 1 | Oct 22, 2025 | s••••••• | biospace.com |
| H••• • H•••••••• G••••••••• | organisation | 1 | Oct 22, 2025 | s••••••• | biospace.com |
- B••••••••• I•••••••• V•••••• F••• ••••• Oct 22, 2025 recurring (2) Fact biospace.com
- H••• • H•••••••• G••••••••• Oct 22, 2025 recurring (2) Fact biospace.com
- U••••••••• F•••••• f•• I••••••••• Oct 22, 2025 recurring (2) Fact biospace.com
- B••••• K•••••• Oct 22, 2025 recurring (2) Fact biospace.com
- B••••••••• I•••••••• V•••••• F••• ••••• Oct 22, 2025 recurring (2) Fact biospace.com
- H••• • H•••••••• G••••••••• Oct 22, 2025 recurring (2) Fact biospace.com
- U••••••••• F•••••• f•• I••••••••• Oct 22, 2025 recurring (2) Fact biospace.com
- B••••• K•••••• Oct 22, 2025 recurring (2) Fact biospace.com
Independent sponsor relationshipsshow
No cited relationship to an independent sponsor.
Related entitiesshow
Signals and timeline5show
Most significant first: what kind of change it is, its size, whose change it is, and how recent. 5 events. 13F position changes are under Public stakes and holdings.
- Oct 22, 2025Office discoveredA••••• A•••• A• named as a single family office on globenewswireDiscoveryFactglobenewswire.com
- Sep 15, 2026Classification changedA••••• A•••• A•: PROBABLE_SFO -> CONFIRMED_SFO (M••••• F•••'s own biography (s•••••••.de, independent of our GlobeNewswire source) names him managing director of 'the single-family office A••••• Holding GmbH' and separately confirms he is a shareholder of Dr. F••• Pharma 'from the F••• family' (per a related search summary on his H••• and F••• Pharma background); A••••• Holding GmbH is the parent entity of A••••• Asset GmbH per German commercial-register data (Northdata).)c•••••••••Factsmartbax.de
- Oct 22, 2025Direct investmentA••••• Asset leads €4.7M Pre-Series A round in antibiotic-resistance biotech s•••••••Direct investmentsFactbiospace.com
- Oct 22, 2025Direct investmentA••••• A•••• A• invested in s•••••••Direct investmentsFactbiospace.com
- Jan 1, 2018Investment professional joinedM••••• F••• becomes managing director of the single-family office A••••• Holding GmbHp•••••Factsmartbax.de
Sources and evidence13show
Every observation behind this profile: the value, when it was effective, the source, the quote where there is one, and whether it is a fact, an inference or an estimate. 13 shown.
Score components
Freshness
+100 d••• s•••• t•• n••••• s••••••••• f••• o• a•••••• v••••••••• (1 days)
Contactability
+30 n•••• d••••••••• (••• Locked)
Data confidence
+10 s••••• m••••••
+10 p•••••
+15 i•••••••••
+10 i••••••••• s•••••• (2 sources)
Active deployment
+25 d•••• p•••••• i••••••••• i• l••• 2• m••••• (s••••••• (2025-10-22))
+25 a• d•••• p•••••• i••••••••• i• l••• 1• m••••• (2025-10-22)
Exists confidence
+20 i••••••••• s•••••• (2 sources)
+30 a•••••••••
Research priority
+15 s••••• f••••• o• f••••• i••••••••• c••••••
+3 d••••• i••••••••• o• r•••••
+10 d••••••• i• l••• 2• m•••••
+2 n• w•••••• k•••• •••••••• w•••• f••• o•••
+0 r••• (234)
Mandate confidence
+10 m•••••• s•••••••• b• o••••••• i•••••••••
+20 s••••• m•••••• o• t•• r•••••
Identity confidence
+75 c••••••••• (••• Locked)
Real estate propensity
no components; scored 0
Co investment propensity
+80 c••••••••• o• t•• r••••• (••• Locked)
Family identity confidence
+60 w••••• o••••• o• o•••••••• c•••••• o• t•• r•••••
+40 f••••• n•••• (F••• family)
Private markets propensity
no components; scored 0
Current activity confidence
+50 d•••• p•••••• i••••••••• i• 2• m•••••
+25 a• s••••••••• f••• w••••• 1• m••••• (335 days)
External manager propensity
no components; scored 0
Direct investment propensity
+15 o••••••• d••••• i••••••••• (1 on the record)
Independent sponsor propensity
no components; scored 0
| Fact | Value | Effective | Source | Class |
|---|---|---|---|---|
| Decision rights | ••• Locked “••• Locked” | Jan 1, 2018 | DFX analyst research (General-assisted, every claim URL-cited) smartbax.de | Fact |
| Family involvement | ••• Locked “••• Locked” | Jan 1, 2017 | DFX analyst research (General-assisted, every claim URL-cited) smartbax.de | Fact |
| Family served | F••• family “••• Locked” | n/a | DFX analyst research (General-assisted, every claim URL-cited) smartbax.de | Fact |
| Headquarters | Freiburg im Breisgau, Germany (Habsburgerstr. 91) “Habsburgerstr. 91, 79104 Freiburg i. Breisgau, Germany” | Sep 21, 2026 | DFX analyst research (General-assisted, every claim URL-cited) northdata.com | Fact |
| Headquarters | Freiburg | Oct 22, 2025 | GlobeNewswire releases that name a family office (discovery and investment records, quoted) globenewswire.com | Fact |
| Invests directly | ••• Locked “••• Locked” | Oct 22, 2025 | DFX analyst research (General-assisted, every claim URL-cited) biospace.com | Fact |
| Office type (stated) | single_family_office “••• Locked” | Sep 15, 2026 | DFX analyst research (General-assisted, every claim URL-cited) smartbax.de | Fact |
| Office type (stated) | single_family_office | Oct 22, 2025 | GlobeNewswire releases that name a family office (discovery and investment records, quoted) globenewswire.com | Fact |
| Sectors | ••• Locked “i••••••••• in the field of venture capital” | Sep 21, 2026 | DFX analyst research (General-assisted, every claim URL-cited) smartbax.de | Fact |
| Source of wealth | ••• Locked “a research-based family business with global presence” | Sep 21, 2026 | DFX analyst research (General-assisted, every claim URL-cited) drfalkpharma.com | Fact |
| Source of wealth | ••• Locked “••• Locked” | Jan 1, 1960 | DFX analyst research (General-assisted, every claim URL-cited) de.wikipedia.org | Fact |
| Website search | not_found | Sep 16, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |
| Website search | not_found | Sep 14, 2026 | DFX model output (c••••••••• rules, scores, mandates, matches) no URL | Inference |